ImmunoGen Inc., a biotechnology company that researches and develops cancer treatments, has hired Daniel Char as senior vice president and chief legal officer.

Char succeeds Craig Barrows, who retired in 2020 after more than 12 years as the Waltham, Massachusetts-based company’s general counsel. Joseph Kenny, who has been acting general counsel since March 2020, will now serve as associate general counsel.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]